Compare CSTL & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTL | MBUU |
|---|---|---|
| Founded | 2007 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 611.1M | 541.4M |
| IPO Year | 2019 | 2013 |
| Metric | CSTL | MBUU |
|---|---|---|
| Price | $21.05 | $27.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $45.50 | $32.20 |
| AVG Volume (30 Days) | ★ 468.8K | 320.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 127.74 |
| EPS | N/A | ★ N/A |
| Revenue | $344,229,000.00 | ★ $807,561,000.00 |
| Revenue This Year | $2.42 | $2.14 |
| Revenue Next Year | $12.69 | $12.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $14.59 | $23.84 |
| 52 Week High | $44.28 | $39.65 |
| Indicator | CSTL | MBUU |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 52.78 |
| Support Level | $17.72 | $24.24 |
| Resistance Level | $24.46 | $27.60 |
| Average True Range (ATR) | 1.12 | 1.35 |
| MACD | 0.37 | 0.10 |
| Stochastic Oscillator | 74.65 | 45.46 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Most recently, in 2026, it tied up with Saxdor Yachts, focused on adventure dayboats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.